Cart
sales@molnova.com
Dehydrotrametenolic acid
CAS No. 29220-16-4
Dehydrotrametenolic acid( —— )
Catalog No. M18377 CAS No. 29220-16-4
Dehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 255 | In Stock |
|
| 50MG | 360 | In Stock |
|
| 100MG | 495 | In Stock |
|
| 200MG | 678 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydrotrametenolic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor.
-
DescriptionDehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor. Dehydrotrametenolic acid is a promising candidate for a new type of insulin-sensitizing drug.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number29220-16-4
-
Formula Weight454.69
-
Molecular FormulaC30H46O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 14.29 mg/mL (31.43 mM)
-
SMILESCC(=CCCC(C1CCC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Beta-Hederin
Beta-Hederin has apoptotic effect on breast cancer cells, it could be a promising candidate for chemotherapy of breast cancer.
-
Phospho(enol)pyruvic...
Phosphoenolpyruvic acid monopotassium salt is involved in glycolysis and gluconeogeneis. In glycolysis PEP is metabolized by Pyruvate Kinase to yield pyruvate. In plants PEP is involved in the formation of aromatic amino acids as well as in the carbon fixation pathway.
-
LC-MB12
LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
